Surprise Me!
Lilly Earnings Beat
2026-04-30
618
Dailymotion
Eli Lilly beat earnings and raised outlook as demand for key drugs surged.
Related Videos
Eli Lilly accused of bribing doctors to prescribe Mounjaro and other drugs
Eli Lilly Misses Q3 Targets, Lowers Full-Year Outlook on Weak Zepbound, Mounjaro Sales
Eli Lilly Q3 Earnings: Mounjaro Sales More Than Double, Takes $2.98 Billion Hit To Profit, Cuts Annual Outlook, Stock Tanks
Eli Lilly Launches Multi-Dose Zepbound Pen to Drive Obesity Drug Growth
Lilly Cuts Prices for Cash Buyers of Weight-Loss Drug Zepbound
Campbell's Earnings Beat; Eli Lilly Obesity Drug Results | Stock Movers
Eli Lilly Slashes Zepbound Prices to Boost Accessibility for Patients and Combat Counterfeit Drugs
Eli Lilly to Cut Prices of Insulin Drugs by 70%
Coronavirus India: Eli Lilly की Antibody Drugs के इस्तेमाल की मंजूरी | वनइंडिया हिंदी
freeworld1 pharmacy Online Pharma is a provider of treatment using drugs, specialty pharmaceuticals and other life saving drugs.
